OTC - ACTIVE INGREDIENT SECTION
Lidocaine 4%
Lidocaine 4%
Topical Aneslhetic
Use Temperarily relicwes miner pain.
For external use only
Do not use More than one patch on your body at a time On gut, initated orswollen gkin On puncture wounds For more than one week without consultinga doctor if you are allergic to any aclive or inactive ingrediantsm lf pouch iscambged or opred.
When using this product Use only as directed Read and follow all directionsand warings on this carton Do not allow oontact with the oyes Do not use atthe same lime as oler bopical analgesics Do nat bandage lighlly or apoly localheat (such as heating pads, to the area of use Dispose of uged patch inmannerihat always keeps product away irom children and pots, Lised paiches siilcontain the drug product that can produce gerious adverge elfecis if a child or petchaws or ingasis ihis patchh.
Stop use and consult a doctor if condtion worsensm Redness is presert lniation develops Sympioms persist for more than 7 dlays or clear up and oocuragain willin a ferw darys You coperienoe signs of skin injury, such as pain, sweling or bllslering where the product was applled.
Keep out of reach of children and pets.
Adults and chldren 12 years of age and over: Clean and dry affected areaCarefully remove backing from patchstarting at a corner. Apply sticky sideof patch to affected area. Use one patch for up to 12 hours. Discard patchaftersingle use. Children under 12 years of age: consult a physician.
Aluminum Glycinate
Aluminum Hydroxide
Cellulose Gum (Sodium CMC)
DMDM Hydantoin
Glycerin
Polyacrylic Acid
Polysorbate 80
Propylene Glycol
Ricinus Communis (Castor) Seed Oil
Silica (Colloidal)
Sodium Polyacrylate
Tartaric Acid
Titanium Dioxide
Urea
Water (Purified Water)
| Class | Version | Type | Effective |
|---|---|---|---|
| LIDOCAINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 070fbed5-7088-434a-a7ce-f2a64d8d40ac | Product name | 2 | 20260107 |
| bee66ce1-adb7-9d3b-67d9-582e4c54e80f | Product name | 5 | 20250819 |
| 860a93dc-4863-49cc-b284-6bbe8191bc48 | Product name | 4 | 20250214 |
| eaba870a-6a9d-442e-8643-87b3f558a451 | Product name | 1 | 20250117 |
| 9b4cf230-fd05-41d5-98c6-5db9ecb27b86 | Product name | 1 | 20230117 |
| 7d755fa1-1087-4dcd-98f0-6d4bba479a57 | Product name | 3 | 20210602 |
| f52be47f-7aa7-46c0-b1fa-50c18dd50206 | Product name | 1 | 20201029 |
| aed701d5-9c75-dfaf-7154-cde46179faea | Product name | 9 | 20200313 |
| fa8b5901-e681-426f-82fe-54f6d81ec698 | Product name | 4 | 20180619 |
| 332d03e4-aa24-4b11-841a-02bf41081920 | Product name | 1 | 20171221 |
| c08ab52f-2fc8-4409-9d9f-ed8edc0bd070 | Product name | 1 | 20171221 |
| 68ed98f8-24c2-44a0-944a-6d36e82ce25a | Product name | 1 | 20141222 |
| 1cd42bc2-a430-c72b-636d-991b235fbf80 | Product name | 1 | 20140508 |
| 49fa150c-f0de-cce7-3d9c-993ed81c5698 | Product name | 1 | 20140508 |
| 4d7ae718-ed00-bae8-2abe-9eaec1eef7ff | Product name | 1 | 20140508 |
| 9137811f-f279-8640-5aeb-99fa2145d64d | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 84735-010-01 | 4% Lidocaine Patch | 20 in 1 BOX | PATCH | 20 | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 84735-010 | 84735-010-01 |
Every source-derived ingredient row is available through these pages.
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 1 | 2025-05-21 | full-release | 2026-06-01 01:01:28 |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 42e8ff2d-7db7-49f1-e063-6394a90ad85e | 35a15e60-b33c-5065-e063-6294a90ad9df | 2025-11-06 | Warnings | 42e8ff2d-7db7-49f1-e063-6394a90ad85e 35a15e60-b33c-5065-e063-6294a90ad9df |
Adverse event summaries are temporarily unavailable. Other product information remains available.